Japan PM Ishiba's Cabinet Approval Hits Record Low, Asahi Reports TOKYO (Reuters) - Public support for Japanese Prime Minister Shigeru Ishiba's government dropped to a record low after he handed ...

For drugs not yet approved in any EU Member State, allowing manufacturers to apply for authorisation in multiple EU countries at the same time. With offices across the EU, Proregulations can ...

She looked ethereal as she slipped into Tony Ward couture. She indeed channelled modern-day princess vibes in a beautiful blue dress that looked every bit stunning/ The strapless gown came with a ...

Then, with your approval, NBKC will automatically transfer your savings into these goals each month. The nbkc Everything Account has no minimums and no monthly fees, making it a great anxiety-free ...

In the US, globetrotting Sichel marketed Blue Nun as ‘the delicious white wine that’s correct with any dish’, boosting sales by 500 per cent Save Comment speech bubble icon ...

For people in Europe, drugs are not an option at all. In 2024, the European Medicines Agency (EMA) rejected market authorization for Syfovre. The agency did not think it offered enough benefit for ...

Donald Trump has made history with record-breaking low approval ratings despite his recent jibes over Volodymyr Zelensky's poll numbers. A majority of Americans disapprove of Mr Trump just weeks ...

AbbVie announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of upadacitinib (Rinvoq; 15 mg, once ...

Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting a marketing ...

Ocugen (OCGN) announced that the European Commission, EC, has provided a positive opinion from the European Medicines Agency’s, EMA, Committee for Advanced Therapies, CAT, for OCU410 and ...

Otulfi ® was approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) in September 2024, having successfully met the agency's standards for biosimilarity to ...